QIMA Bioalternatives is a contract research organization (CRO) established in 1996 and specializing in cellular and molecular pharmacology.
Our testing offering ranges from virtual in silico screening to clinical imaging, in vitro and ex vivo testing, as well as bioanalysis of non-invasive clinical samples.